Time to castration-resistant prostate cancer is defined by prostate-­specific antigen progression and may represent a risk factor for developing immune alterations with a negative prognostic role in the overall survival of patients with prostate cancer. This evidence concerns the gene KLK3 and prostate carcinoma.